Synthetic Biologics (SYN) Scheduled to Post Quarterly Earnings on Thursday

Synthetic Biologics (NASDAQ:SYN) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 8th. Analysts expect the company to announce earnings of ($1.32) per share for the quarter.

Synthetic Biologics (NASDAQ:SYN) last issued its quarterly earnings data on Wednesday, August 8th. The company reported ($1.05) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.40) by $0.35.

NASDAQ SYN opened at $0.87 on Wednesday. Synthetic Biologics has a 12-month low of $0.77 and a 12-month high of $26.60.

TRADEMARK VIOLATION NOTICE: “Synthetic Biologics (SYN) Scheduled to Post Quarterly Earnings on Thursday” was posted by WKRB News and is owned by of WKRB News. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.wkrb13.com/2018/11/07/synthetic-biologics-syn-scheduled-to-post-quarterly-earnings-on-thursday.html.

Synthetic Biologics Company Profile

Synthetic Biologics, Inc, a late-stage clinical company, develops therapeutics designed to preserve the microbiome to protect and restore the health of patients. Its lead product candidates are in Phase III development, such as SYN-004 that is designed to protect the gut microbiome from the effects of commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C.

Read More: Are Wall Street analysts’ stock ratings worth following?

Earnings History for Synthetic Biologics (NASDAQ:SYN)

Receive News & Ratings for Synthetic Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthetic Biologics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply